Startup raises â¹2,300 crore for cancer-detecting blood test
Biotech startup Guardant Health, led by Stanford graduate Helmy Eltoukhy, has raised $360 million (â¹2,300 crore) to develop blood tests that detect and track cancer. The round was led by SoftBank, with participation from Sequoia Capital and Lightspeed Venture Partners among others. Guardant's test will measure DNA released by tumours in bloodstream and is pegged as an alternative to biopsy.